American College of Clinical Pharmacy ®

Tuesday, February 22, 2022 from 9:00 AM–11:00 AM EST
Available for 2.00 hours of CPE credit
Activity Number: 0217-0000-22-008-L01-P

Moderator: Erika J. Ernst, Pharm.D., FCCP, BCIDP Associate Professor, Department of Pharmacy Practice and Science, University of Iowa College of Pharmacy; Clinical Pharmacy Specialist, infectious diseases, University of Iowa Hospitals and Clinics, Iowa City, Iowa View Biography	Ernst
Faculty: Michael B. Kays, Pharm.D., FCCP, BCIDP Associate Professor of Pharmacy Practice, Purdue University College of Pharmacy; Clinical Specialist, Infectious Diseases at IU Health, Methodist Hospital; Adjunct Associate Professor of Medicine, Indiana University School of Medicine, Indianapolis, Indiana View Biography	Kays

9:00 AM–11:00 AM

Develop a treatment plan and evaluate clinical outcomes for patients with serious infections caused by extended-spectrum beta-lactamase-producing gram-negative pathogens.
Develop a treatment plan and evaluate clinical outcomes for patients with serious infections caused by carbapenem-resistant Enterobacterales.
Develop a treatment plan and evaluate clinical outcomes for patients with serious infections caused by multidrug-resistant Pseudomonas aeruginosa.
Develop a treatment plan and evaluate clinical outcomes for patients with carbapenem-resistant Acinetobacter baumannii and Stenotrophomonas maltophilia.
Develop a treatment plan and evaluate clinical outcomes for patients with latent and active infections caused by multidrug-resistant tuberculosis.

Back to Schedule

Back to Symposium